Healthcare

Reversing Drug Resistance: Dr. Anita Davidson on Innovation, Patient Advocacy & Creative BioTherapeutics' Breakthrough Cancer Therapies

Dr. Anita Davidson — CEO, Creative BioTherapeutics LLC

In this powerful and eye-opening Xraised interview, we sit down with Dr. Anita Davidson, CEO and Co-Founder of Creative BioTherapeutics (CBT), to explore one of the most urgent frontiers in healthcare: reversing drug and immune resistance in late-stage cancers and viral diseases. With over 35 years of experience in healthcare innovation, entrepreneurship, and patient advocacy, Dr. Davidson shares how her personal and professional journey led to the creation of a biotech company determined to challenge the status quo and redefine what’s possible for patients who have run out of options.

Dr. Davidson reveals the defining moment that sparked her shift into biotech — a moment that highlighted the limitations of traditional pharmaceutical systems and inspired the mission behind Creative BioTherapeutics: to create non-toxic, multi-pathway therapies engineered to reverse drug and immune resistance in deadly diseases. She explains how CBT’s scientific approach differs fundamentally from conventional oncology strategies by focusing on why cancers recur, why they resist treatment, and how their survival mechanisms can be dismantled upstream.

Comments

Leave this field empty

I agree that my name and comment may be published after review. My email, if given, stays private. Post comment

No comments yet — be the first to share your thoughts.